India approves J&J COVID-19 vaccine for emergency use

Reuters2021-08-07

Aug 7 (Reuters) - India approved Johnson & Johnson's single-dose COVID-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet.

The pharmaceutical giant had applied for emergency use approval on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
207